Barcoding proteins for a universal disease - diagnostic system in medicine

ProteinLogic Ltd's unique technology barcodes human diseases using a discreet set of biomarkers present in body fluids. This offers a rational solution to the content 'problem' that has limited the use of proteomics. These biomarkers appear to be universal and derive a specific pattern in every major type of pathology tested. This 'one set does all'; approach is unique, and has the power to make a fundamental impact on many aspects of clinical medicine.

ProteinLogic News

24 March 2009: ProteinLogic closes Private Placing

30 September 2008: ProteinLogic announces collaboration with the Immune Tolerance Network

02 July 2008: ProteinLogic patent granted by Australian Patent Office

17 June 2008: Diagnostic testing method deemed patentable by Australian Patent Office

This website may include forward-looking statements. Actual results might differ materially from those projected in any such forward-looking statements, which involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, market acceptance, intellectual property or achievements to be materially different from any future results, levels of activity, performance, market acceptance, intellectual property or achievements expressed or implied by the forward-looking statements. Although ProteinLogic (the Company) believe the expectations reflected in forward-looking statements are reasonable the Company cannot guarantee future results, levels of activity, performance, market acceptance, intellectual property or achievements